Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Analysis of germline modifiers of aggressive prostate cancer using cross-species variation and systems genetics

ABSTRACT: Analysis of germline modifiers of aggressive prostate cancer using cross-species variation and systems genetics

PROVIDER: PRJNA344903 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR4451770_1.fastq.gz	Fastqsanger.gz
	SRR4451770_2.fastq.gz	Fastqsanger.gz
	SRR4451780_1.fastq.gz	Fastqsanger.gz
	SRR4451780_2.fastq.gz	Fastqsanger.gz
	SRR4451790_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 2838

Similar Datasets

Analysis of germline modifiers of aggressive prostate cancer using cross-species variation and systems genetics

Project description:This SuperSeries is composed of the SubSeries listed below.

2017-01-01 | GSE87491 | GEO

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas

Project description:Cancer stem cells (CSCs) are plastic in nature, a characteristic that hampers cancer therapeutics. Neuroblastoma (NB) is a pediatric tumor of neural crest origin, and half of the cases are highly aggressive. By treating NB cell lines (SKNAS, SKNBE(2)C, CHP134, SY5Y) with epigenetic modifiers for a short time followed by sphere-forming culture conditions, we have established stem cell-like NB cells that are phenotypically stable for over a year. These cells are characterized by their high expression of stemness factors, stem cell markers, and open chromatin structure. We referred to these cells as induced CSC (iCSC). SKNAS iCSC and SKNBE(2)C iCSC clones (as few as 100 cells) injected subcutaneously into SCID/Beige mice formed tumors, and in one case, SKNBE(2)C iCSC metastasized to the adrenal gland, suggesting their increased metastatic potential. SKNAS iCSC xenografts showed the histologic appearance of totally undifferentiated “large-cell” NBs (LCNs), the most aggressive and deadly form of NB in humans. Immunohistochemical analyses showed that SKNAS iCSC xenografts expressed high levels of the stem cell marker CXCR4, while the SKNAS monolayer cell xenografts did not. The patterns of CXCR4 and MYC expression in SKNAS iCSC xenografts resembled those in the LCNs. The xenografts established from the NB iCSCs shared two common features: the LCN phenotype and high-level MYC/MYCN expression. These observations suggest that NB cells with large and vesicular nuclei, representing their open chromatin structure, are indicative of stem cell-like tumor cells, and that epigenetic changes may have contributed to the development of these most malignant NB cells. Gene expression profiles of SKNAS monolayer culture, sphere culture and iCSC culture were comparatively analyzed to examine the stem cell phenotype of each culture condition.

2013-04-02 | E-GEOD-44537 | biostudies-arrayexpress

A forward genetics screen identifies modifiers of Rocaglate responsiveness

Project description:A forward genetics screen identifies modifiers of Rocaglate responsiveness

| PRJNA703979 | ENA

Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas

2013-04-02 | GSE44537 | GEO

Variation in germline gene expression in cde-1 mutant

Project description:analysis of germline gene expression in wildtype and cde-1 mutant C. elegans.

2009-10-02 | GSE18202 | GEO

Genetic Modifiers of Huntington's Disease

Project description:Genetic Modifiers of Huntington's Disease

| PRJNA75833 | ENA

Transcription profiling of mouse inbred strains to identify germline cancer modifiers using parental strain expression mapping

Project description:Inherited genetic risk factors play an important role in cancer. However, other than cancer susceptibility genes found in familial cancer syndromes and inherited in a Mendelian fashion, little is known about modifier genes (germline variants that interact with each other and with environmental factors) that contribute to individual susceptibility. Here we develop a strategy âparental strain expression mappingâ (PSEM), which utilizes the homogeneity of inbred mice and genome-wide mRNA expression analyses, to directly identify candidate germline modifier genes and pathways underlying phenotypic differences among murine strains exposed to transgenic activation of AKT1. We identified multiple candidate modifier pathways and specifically, the glycolysis pathway as a candidate negative modulator of AKT1-induced proliferation. In keeping with findings in murine models, the expression of the glycolysis pathway was strongly enriched in the non-cancer prostate tissue from patients with prostate cancer who did not recur after surgical resection. Together these data suggest that PSEM can directly identify germline modifier pathways of relevance to human disease. Experiment Overall Design: mRNA expression profiling was carried out with 24 samples of VP from 6 inbred strains.

2008-06-15 | E-GEOD-7270 | biostudies-arrayexpress

Expression data from prostate tumors of TRAMPxPWK/PhJ F2 cross

Project description:We hypothesize that germline variation influences susceptibility to aggressive prostate tumor We examined the changes in gene expression in tumors obtained from TRAMPxPWK/PhJ F2 mice

2015-12-15 | GSE61864 | GEO

Expression data from prostate tumor of TRAMPxNOD/ShiLtJ F2 cross

2015-06-25 | GSE58829 | GEO

Genetics of CMT - Modifiers of CMT1A, New Causes of CMT - INC 6602

Project description:Genetics of CMT - Modifiers of CMT1A, New Causes of CMT - INC 6602

| PRJNA512548 | ENA